Call Options Transactions Made in Q2 2024 in Day One Biopharmaceuticals, Inc. (DAWN)
This table provides information about the institutional ownership of Day One Biopharmaceuticals, Inc. (DAWN) during Q2 2024. The information is specifically focused on institutions that hold call options of Day One Biopharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 12, 2024
Q2 2024
|
Citigroup Inc
|
BUY
|
CALL |
30KNew |
$361K - $531K
|
30K
$381K
|
|
|
Aug 14, 2024
Q2 2024
|
Torno Capital, LLC
Cohasset, MA |
BUY
|
CALL |
30KNew |
$361K - $531K
|
30K
$381K
|
|
|
Aug 14, 2024
Q2 2024
|
Caption Management, LLC
Oklahoma City, OK |
BUY
|
CALL |
25KNew |
$301K - $442K
|
25K
$317K
|
|
|
Aug 15, 2024
Q2 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
22KNew |
$265K - $389K
|
22K
$279K
|
|
|
Aug 14, 2024
Q2 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
10.8K+ 70.59% |
$130K - $191K
|
26.1K
$331K
|
|
|
Aug 14, 2024
Q2 2024
|
Bank Of America Corp
Charlotte, NC |
SELL
|
CALL |
-2.2K- 6.79% |
$26.5K - $38.9K
|
30.2K
$383K
|